A 51-year-old woman was diagnosed with systemic lupus erythematosus (SLE) with nephritis. High-dose corticosteroid and intravenous cyclophosphamide (IVCY) therapy was administrated, and the disease activity of SLE was improved; however, a blood examination showed elevated levels of aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase after these therapies. Therefore, IVCY was discontinued because drug-induced liver dysfunction was suspected; however, the elevation of liver enzymes continued to worsen. Contrast-enhanced computed tomography showed homogeneous contrast enhancement during the hepatic arterial phase ([Picture A](#g001){ref-type="fig"}). Contrast-enhanced ultrasonography using Sonazoid revealed a hyperechoic peliotic lesion ([@B1]) ([Picture B](#g001){ref-type="fig"}). These radiological findings strongly suggested peliosis hepatis (PH). A histological examination was not performed because a liver biopsy was considered to carry a high risk of intraperitoneal bleeding. Reducing the dose of corticosteroid improved the liver dysfunction and the radiological findings ([Picture C](#g001){ref-type="fig"}). Most patients with PH are asymptomatic; however, some afflicted patients have died after developing rupture of peliosis ([@B2]). Corticosteroid-induced PH is reported to be reversible. Therefore, clinicians should recall that corticosteroids are a causative drug of liver dysfunction in daily practice.
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